Grade 3 or 4 hematologic toxicity was more frequent in patients assigned to 5-FU bolus (31% v 4%; P < 10(-16)), whereas hand-foot syndrome was more frequent in the 5-FU CI group (34% v 13%; P < 10(-7) ...

The toxicities considered were World Health Organization (WHO) grade 3 to 4 anemia, thrombopenia, leukopenia, neutropenia, nausea/vomiting, diarrhea, mucositis, and hand-foot syndrome. Hematologic ...

Hand-foot syndrome (HFS) is a rare condition that causes burning, numbness, tingling, and swelling on the hands and feet. In severe cases, the skin may blister or develop ulcers. HFS is a typical ...

female reproductive system For patients with ovarian cancer taking pegylated liposomal doxorubicin who have hand-foot syndrome ... in the PLD group and 9% (5) of patients in the PLD+CBDCA group ...

ORLANDO—Patients with metastatic renal cell carcincoma (RCC) who develop hand-foot syndrome (HFS ... free survival to interferon-alpha (11 vs. 5 months) as first-line metastatic RCC therapy.

What is hand-foot syndrome Palmar-Plantar Erythrodysesthesia, also called hand-foot syndrome,is a side effect which can occur with several types of chemotherapy or biologic therapy drugs used to ...

Certain chemotherapy drugs, notably capecitabine, can cause a side effect known as palmar-plantar erythrodysesthesia (hand-foot syndrome), a painful swelling and inflammation of the hands and feet ...